Thiazolidinedione Inhibition of Peritoneal Inflammation
article
OA: closed
CC0
⤵ 23 in-corpus citations
AI-generated summary
Thiazolidinediones like ciglitazone inhibited macrophage infiltration and pro-inflammatory cytokine secretion in a murine model of peritoneal inflammation.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Chemoattraction of macrophages into the peritoneal cavity is one of the important characteristics in patients with endometriosis. An inflammatory response is postulated to be responsible for infertility and pelvic pain associated with this syndrome. The present in vivo studies were designed to test if thiazolidinediones (TZDs), activators of peroxisome proliferator activated receptor gamma, could inhibit monocyte chemotaxis in a murine model. TZDs were first used as orally bioavailable insulin-sensitizing agents. They are currently under investigation in the treatment of inflammatory diseases, including arthritis or colitis. Intraperitoneal injection of thioglycollate was used to elicit high numbers of activated peritoneal macrophages in female mice. Concomitant peritoneal injection of ciglitazone, a member of the TZD family, significantly reduced the number of macrophages. When cultured and stimulated by tumor necrosis factor alpha, these peritoneal macrophages also secreted less RANTES and less IL-1beta protein. This animal model suggests that treatment of endometriosis patients with TZDs may diminish symptoms associated with intraperitoneal inflammation.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (25)
- An elicited intraperitoneal inflammatory response has no effect on the establishment of pregnancy in the mouse via openalex
- Chemokine bioactivity of RANTES in endometriotic and normal endometrial stromal cells and peritoneal fluid via openalex
- Enhanced Expression of Resident Leukocyte Interferon γ mRNA in Endometriosis via openalex
- Heterologous transplantation of activated murine peritoneal macrophages inhibits gamete interaction in vivo: a paradigm for endometriosis-associated subfertility via openalex
- Immunolocalization and Regulation of the Chemokine RANTES in Human Endometrial and Endometriosis Tissues and Cells via openalex
- Immunolocalization and Regulation of the Chemokine RANTES in Human Endometrial and Endometriosis Tissues and Cells<sup>1</sup> via openalex
- Increased activation of pelvic macrophages in infertile women with mild endometriosis via openalex
- Inflammatory reaction in endometriotic tissue: an immunohistochemical study via openalex
- Lymphocyte activity in the presence of peritoneal fluid from fertile women and infertile women with and without endometriosis via openalex
- Nuclear Peroxisome Proliferator-Activated Receptors and Have Opposing Effects on Monocyte Chemotaxis in Endometriosis via openalex
- Nuclear Peroxisome Proliferator-Activated Receptors α and γ Have Opposing Effects on Monocyte Chemotaxis in Endometriosis via openalex
- Peritoneal fluid concentrations of the cytokine RANTES correlate with the severity of endometriosis via openalex
- Peritoneal macrophages and infertility: the association between cell number and pelvic pathology via openalex
- Regulated on Activation, Normal T-Cell-Expressed and -Secreted mRNA Expression in Normal Endometrium and Endometriotic Implants via openalex
- W2040003495 via openalex
- W1511195742 via openalex
- W1945626132 via openalex
- W1975879084 via openalex
- W2003115027 via openalex
- W2011419421 via openalex
- W1491039670 via openalex
- W2153054296 via openalex
- W2409510670 via openalex
- W2418373307 via openalex
- W4245444381 via openalex
Cited by (23)
- Endometriosis diagnosis and medical treatment: Present and future 2021
- PPARγ Activation Inhibits Growth and Survival of Human Endometriotic Cells by Suppressing Estrogen Biosynthesis and PGE2 Signaling. 2013
- Peroxisome proliferator-activated receptor γ agonist suppresses human telomerase reverse transcriptase expression and aromatase activity in eutopic endometrial stromal cells from endometriosis 2013
- Endometriosis 2013
- Peroxisome proliferating activating receptor gamma–independent attenuation of interleukin 6 and interleukin 8 secretion from primary endometrial stromal cells by thiazolidinediones 2011
- PPAR–gamma: a dagger in endometriosis 2010
- NF-κB Decoy Oligonucleotides Suppress RANTES Expression and Monocyte Chemotactic Activity via NF-κB Inactivation in Stromal Cells of Ectopic Endometrium 2009
- Endometriosis 2009
- Thiazolidinediones as Therapy for Endometriosis: A Case Series 2009
- A Botanical Extract from Channel Flow Inhibits Cell Proliferation, Induces Apoptosis, and Suppresses CCL5 in Human Endometriotic Stromal Cells1 2009
- Peroxisome-proliferator activator receptor-gamma activation decreases attachment of endometrial cells to peritoneal mesothelial cells in an in vitro model of the early endometriotic lesion 2009
- Peroxisome proliferator-activated receptor-gamma and retinoid X receptor agonists synergistically suppress proliferation of immortalized endometrial stromal cells 2008
- Emerging drugs for endometriosis 2008
- Endometriose und Inflammation 2007
- Emerging drugs in endometriosis 2006
- Leflunomide—an Immunomodulator—Induces Regression of Endometrial Explants in a Rat Model of Endometriosis 2006
- Role of immunologic and inflammatory factors in the development of endometriosis: indications for treatment strategies 2005
- Sulindac Suppresses Nuclear Factor-κB Activation and RANTES Gene and Protein Expression in Endometrial Stromal Cells from Women with Endometriosis 2005
- Role of immunologic and inflammatory factors in the development of endometriosis: indications for treatment strategies 2005
- Antiinflammatorische Therapie bei Endometriose 2004
- Entstehung und Pathogenese 2004
- Association of peroxisome proliferator–activated receptor gamma 2 Pro-12-Ala polymorphism with endometriosis 2004
- Potential involvement of the immune system in the development of endometriosis 2003
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:12:55.732728+00:00
License: CC0
· commercial use OK